Suboptimal oral anticoagulation in patients with nonvalvular atrial fibrillation and history of cerebrovascular disease in Mexico. Results from CARMEN-AF Registry
Revista de Investigación Clínica · 2025
DOI: 10.1016/j.ric.2025.100003 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Revista de Investigación Clínica, 2025. Verfasst von Carlos Cantú-Brito und 39 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de Mexico, Mexico. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Cerebrovascular Disorders, Stroke. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías.
Abstract (Originalsprache)
BACKGROUND: Atrial fibrillation (AF) increases the risk of stroke, especially in patients with previous cerebrovascular disease. This risk is significantly reduced with oral anticoagulants (OAC), with direct oral anticoagulants (DOACs) being the optimal treatment. OBJECTIVES: To study the most used anticoagulant treatment in patients with nonvalvular AF (NVAF) with and without cerebrovascular disease in Mexico. METHODS: CARMEN-AF is a national, multicentric observational registry that includes 1423 patients with AF. Patients were recruited regardless of the anticoagulant therapy. Demographics, clinical variables, comorbidities and antithrombotic treatment were compared among patients with and without a history of cerebrovascular disease. RESULTS: Of the 238 patients with a previous cerebrovascular disease (average age 69±13 years; 114 women [48.5%]), 99% had a previous ischemic stroke. In this subgroup, the type of AF was permanent 43.4%, persistent 20%, and paroxysmal AF was 36.6%. Principal comorbidities were hypertension 77.9%, diabetes mellitus 29.8%, and heart failure 20%. Nearly 12.4% of patients with a history of ischemic cerebrovascular disease did not receive anticoagulant (AC) treatment. Among those who did, vitamin K antagonists (VKAs) were more commonly prescribed than DOACs (37.4% vs. 25.5%). CONCLUSION: In Mexico, anticoagulation rates remain low among patients with NVAF and a history of cerebrovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de Mexico, Mexico.
- Research and Graduate Center, Academic Division of Health Sciences, Universidad Juárez Autónoma de Tabasco (UJAT), Villahermosa, Tabasco, Mexico.
- Cardiology Outpatient Consultation, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de Mexico, Mexico.
- Unidad Médica de Alta Especialidad del Hospital de Especialidades "Dr. Antonio Fraga Mouret", Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.
- Hospital Regional de PEMEX Ciudad Madero, Tamaulipas, Mexico.
- Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosí, Mexico.
Förderung
- Consejo Nacional de Humanidades, Ciencias y Tecnologías
Zitieren
APA
Cantú-Brito, C., Baños-González, M. A., González-Hermosillo, J. A., Guevara-Valdivia, M. E., Vázquez-Acosta, J. A., Leiva-Pons, J. L., Lechuga-Martin Del Campo, A., Rodríguez-Reyes, H., Manzano-Cabada, J., Márquez-Murillo, M. F., Participating researchers of the CARMEN-AF Registry, Odín de Los Ríos-Ibarra, M., Aguilar-Linares, J. A., Pozas-Garza, G., Favela-Pérez, E. A., Molina-Fernández de Lara, L., Magaña Magaña, R., Camacho-Casillas, R., Vásquez-Serna, C., …, & Sánchez-Ramírez, M. I. (2025). Suboptimal oral anticoagulation in patients with nonvalvular atrial fibrillation and history of cerebrovascular disease in Mexico. Results from CARMEN-AF Registry. Revista de Investigación Clínica. https://doi.org/10.1016/j.ric.2025.100003
Vancouver
Cantú-Brito C, Baños-González MA, González-Hermosillo JA, Guevara-Valdivia ME, Vázquez-Acosta JA, Leiva-Pons JL, et al. Suboptimal oral anticoagulation in patients with nonvalvular atrial fibrillation and history of cerebrovascular disease in Mexico. Results from CARMEN-AF Registry. Revista de Investigación Clínica. 2025. doi:10.1016/j.ric.2025.100003
BibTeX
@article{CantBrito2025,
author = {Cantú-Brito, Carlos and Baños-González, Manuel Alfonso and González-Hermosillo, Jesus Antonio and Guevara-Valdivia, Milton Ernesto and Vázquez-Acosta, Jorge Abel and Leiva-Pons, José Luis and Lechuga-Martin Del Campo, Alejandro and Rodríguez-Reyes, Humberto and Manzano-Cabada, Janneth and Márquez-Murillo, Manlio Fabio and Participating researchers of the CARMEN-AF Registry, Participating researchers of the CARMEN-AF Registry and Odín de Los Ríos-Ibarra, Manuel and Aguilar-Linares, Julio Alberto and Pozas-Garza, Gerardo and Favela-Pérez, Eddie Alberto and Molina-Fernández de Lara, Luis and Magaña Magaña, Reynaldo and Camacho-Casillas, Rocío and Vásquez-Serna, Cesar and Matadamas-Hernández, Norberto and Rojel-Martínez, Ulises and Negrete-Rivera, Miguel and Fernández-Saldaña, Héctor and Islava-Galvez, Marco and Betancourt-Hernández, Lidia and Kosturakis-García, Demetrio and Baños-Velasco, Alberto and Beltrán-Gámez, Miguel and Lara-Vaca, Susano and Novelo-Del Valle, José Luis and Delgado-Leal, Luis and Trujillo-Muñoz, Luis and Isaac-Márquez, Raúl and Martínez-Flores, Enrique and Reyes-Reyes, Nicolás and Esturau-Santaló, Ramón Miguel and Hernández-Díaz, José Fabián and Núñez-Fragoso, Juan Carlos and Enciso Muñoz, José Manuel and Sánchez-Ramírez, María Isabel},
title = {Suboptimal oral anticoagulation in patients with nonvalvular atrial fibrillation and history of cerebrovascular disease in Mexico. Results from CARMEN-AF Registry},
journal = {Revista de Investigación Clínica},
year = {2025},
doi = {10.1016/j.ric.2025.100003}
}
EUVIMED